An Information Portal to 111749 Biological Macromolecular Structures

(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
LFX is found in 3 entries
  •   Chemical Component Summary   Hide
    Name (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
    Synonyms Levofloxacin
    Formula C18 H20 F N3 O4
    Molecular Weight 361.37 g/mol
    Type non-polymer
    Isomeric SMILES
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01165   (Different stereochemistry)
    Name Ofloxacin
    Groups approved
    Description A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. [PubChem]
    • 8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
    • Ofloxacine
    • Ofloxacino
    • Ofloxacinum
    • OFLX
    Brand names
    • Ocuflox
    • Ofloxacin
    • Ofloxacin Ophthalmic
    • Ofloxacin Otic
    Affected organism Enteric bacteria and other eubacteria
    Indication For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.
    Pharmacology Ofloxacin is a quinolone/fluoroquinolone antibiotic. Ofloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria.
    Mechanism of action Ofloxacin acts on DNA gyrase and toposiomerase IV, enzymes which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription. By inhibiting their function, the drug thereby inhibits normal cell division.
    Route of administration
    • auricular (otic)
    • ophthalmic
    • oral
    • Anti-Bacterial Agents
    • Nucleic Acid Synthesis Inhibitors
    • Anti-Infective Agents
    • Anti-Infective Agents, Urinary
    • Quinolones
    • J01MA01
    • S01AE01
    • S02AA16
    • 08:12.18
    • 52:04.04
    CAS number 82419-36-1
    Name Sequence search Pharmacological action Actions
    DNA gyrase subunit A   Search  yes inhibitor
    DNA topoisomerase 4 subunit A   Search  yes inhibitor
    DNA topoisomerase 2-alpha   Search  unknown inhibitor
    DNA topoisomerase 2-alpha   Search  unknown inhibitor
Ligand Image